Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.
Riad SalemSiddharth A PadiaMarnix LamCarlo ChiesaPaul HasteBruno SangroBeau ToskichKirk FowersJoseph M HermanS Cheenu KappadathThomas LeungDaniel Y SzeEdward KimEtienne GarinPublished in: European journal of nuclear medicine and molecular imaging (2022)
Updated consensus recommendations are provided to guide clinical and dosimetric approaches for the use of Y-90 glass microsphere TARE in HCC, accounting for disease presentation, tumor biology, and treatment intent.